SCHEMBL29366115

SCHEMBL29366115

CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 4/20 0.56
▸ CALCR P30988 7/20 0.55
▸ RAMP3 O60896 6/20 0.55
▸ KEAP1 Q14145 1/20 0.55
▸ GLP1R P43220 2/20 0.54
▸ MAPK8 P45983 1/20 0.54
▸ MAPK9 P45984 1/20 0.54
▸ MAPK10 P53779 1/20 0.54
▸ GCGR P47871 1/20 0.54
▸ GIPR P48546 1/20 0.54
▸ CXCR4 P61073 1/20 0.53
▸ NPY1R P25929 1/20 0.53
▸ NPY2R P49146 1/20 0.53
▸ NPY4R P50391 1/20 0.53
▸ NPY5R Q15761 1/20 0.53
▸ EP300 Q09472 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ CTSL P07711 1/20 0.53
▸ CTSS P25774 1/20 0.53
▸ CTSK P43235 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38652641 0.89 F2 (0.59) F2CALCRRAMP3GLP1RNPY1R
SCHEMBL30723555 0.88 F2 (0.56) F2CALCRRAMP3MAPK8MAPK9
SCHEMBL30262103 0.87 F2 (0.60) F2CALCRRAMP3MAPK8MAPK9
SCHEMBL30432430 0.87 NPY2R (0.64) CALCRRAMP3CXCR4NPY1RNPY2R
SCHEMBL30607365 0.87 GLP1R (0.59) F2CALCRRAMP3GLP1RGCGR
SCHEMBL29943968 0.86 CALCR (0.60) CALCRRAMP3KEAP1GLP1RGCGR
SCHEMBL30495660 0.86 CALCR (0.58) F2CALCRCXCR4NPY1RNPY2R
SCHEMBL30883208 0.86 CALCR (0.68) CALCRGLP1RCXCR4NPY1RNPY2R
SCHEMBL31182767 0.86 CALCR (0.67) F2CALCRKEAP1GLP1RGCGR
SCHEMBL30431826 0.86 CALCR (0.59) F2CALCRNPY1RNPY2RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3967327-B1 TROLOX-PEPTIDE CONJUGATE AND USE THEREOF CAREGEN CO LTD (KR) 2026-01-07 — — EP disclosed
CN-114007579-B Trolox-peptide conjugates and uses thereof 凯尔格恩有限公司 2023-09-12 — — CN disclosed
US-11617796-B2 Conjugate of minoxidil and peptide CAREGEN CO., LTD. (KR) 2023-04-04 — — US disclosed
CN-110520162-B Combination of salicylic acid and peptide 凯尔格恩有限公司 2023-02-17 — — CN disclosed
EP-3501545-B1 CONJUGATE OF MINOXIDIL AND PEPTIDE CAREGEN CO LTD (KR) 2022-10-26 — — EP disclosed
CN-109715217-B Minoxidil and peptide conjugates 凯尔格恩有限公司 2022-07-29 — — CN disclosed
US-11357783-B2 Conjugate of finasteride with peptide CAREGEN CO., LTD. (KR) 2022-06-14 — — US disclosed
EP-3967327-A2 TROLOX-PEPTIDE CONJUGATE AND USE THEREOF Caregen Co., Ltd. (KR) 2022-03-16 — — EP disclosed
CN-114007579-A Trolox-peptide conjugates and uses thereof 凯尔格恩有限公司 2022-02-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11357783-B2 Conjugate of finasteride with peptide CYP17A1, SHBG, PSAP F2 2612/4885CALCR 1983/4885RAMP3 2444/4885
US-11617796-B2 Conjugate of minoxidil and peptide TYR, FGF2, MC1R F2 1649/4885CALCR 3503/4885RAMP3 2348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback